Last $13.65 USD
Change Today -0.29 / -2.08%
Volume 760.3K
MNTA On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
As of 8:10 PM 02/27/15 All times are local (Market data is delayed by at least 15 minutes).

Audit Committee* - momenta pharmaceuticals inc (MNTA)

Name (Connections)Board RelationshipsTitleKey Developments
James Sulat MBA 52 RelationshipsChairman, Member of Audit Committee and Member of Nominating & Corporate Governance Committee 
John Clarke 110 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee 
Marsha Fanucci 60 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance Committee 
Bruce Downey J.D. 56 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee 

Compensation Committee* - momenta pharmaceuticals inc (MNTA)

Name (Connections)Board RelationshipsTitle
John Clarke 110 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee
Bruce Downey J.D. 56 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
Thomas Koestler Ph.D. 64 RelationshipsDirector, Member of Compensation Committee and Member of Science Committee
Bennett Shapiro M.D. 114 RelationshipsIndependent Director, Chairman of Science Committee and Member of Compensation Committee
MNTA Compensation vs. Industry
621.0K
317.9K
Chief Executive Officer
362.5K
232.9K
Chief Financial Officer
Share price activity for MOMENTA PHARMACEUTICALS INC (MNTA)
52 Week Price Performance
MNTA
Industry Average

Nominating Committee* - momenta pharmaceuticals inc (MNTA)

Name (Connections)Board RelationshipsTitleKey Developments
James Sulat MBA 52 RelationshipsChairman, Member of Audit Committee and Member of Nominating & Corporate Governance CommitteePeter Barton Hutt to Retire from Momenta Pharmaceuticals Inc.'s Board of Directors, Effective December 31, 2014
12/15/14
Marsha Fanucci 60 RelationshipsIndependent Director, Chairman of Audit Committee and Member of Nominating & Corporate Governance CommitteeMomenta Pharmaceuticals Inc. Appoints Michael Franken as President, Biosimilars Business
12/12/13
Elizabeth Stoner M.D., M.S. 53 RelationshipsDirector, Member of Nominating & Corporate Governance Committee and Member of Science CommitteeMomenta Pharmaceuticals Inc. Appoints Nic G. Scalfarotto, D.V.M. as Vice President of Regulatory Affairs
05/12/11

Corporate Governance Committee* - momenta pharmaceuticals inc (MNTA)

Name (Connections)Board RelationshipsTitle
Marsha Fanucci 60 RelationshipsIndependent Director, Chairman of Compensation Committee and Member of Audit Committee
Elizabeth Stoner M.D., M.S. 53 RelationshipsDirector, Member of Audit Committee and Member of Compensation Committee
James Sulat MBA 52 RelationshipsDirector, Member of Compensation Committee and Member of Science Committee
MNTA and Competitor
Insiders vs. External
Board
5%
95%
Momenta Pharmaceuticals Inc.
17%
83%
SciClone Pharmaceuticals, Inc.
25%
75%
OraSure Technologies, Inc.
20%
80%
Sucampo Pharmaceuticals, Inc.
38%
62%
Natco Pharma Limited
25%
75%
Pernix Therapeutics Holdings, Inc.
Insiders
External Board Members

Advisory Committee* - momenta pharmaceuticals inc (MNTA)

Name (Board Relationships)/Title Board Affiliations
Elliott Antman 19 Relationships
Member of Scientific Advisory Board
No other board affiliations
K. Austen 59 Relationships
Member of Scientific Advisory Board
No other board affiliations
Carolyn Bertozzi 39 Relationships
Member of Scientific Advisory Board
No other board affiliations
Eugene Braunwald 41 Relationships
Member of Scientific Advisory Board
No other board affiliations
Francis Bullock 63 Relationships
Member of Scientific Advisory Board
No other board affiliations
Benito Casu 38 Relationships
Member of Scientific Advisory Board
No other board affiliations
Richard Cooper 19 Relationships
Member of Regulatory Advisory Board
No other board affiliations
J. Crout 21 Relationships
Member of Regulatory Advisory Board
No other board affiliations
Thomas Garvey 19 Relationships
Member of Regulatory Advisory Board
No other board affiliations
Robert Pollock 32 Relationships
Member of Regulatory Advisory Board
No other board affiliations
William Reardon 55 Relationships
Advisor to Audit Committee
No other board affiliations
Phillips Robbins 19 Relationships
Member of Scientific Advisory Board
No other board affiliations
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MNTA:US $13.65 USD -0.29

MNTA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Natco Pharma Ltd 1,374 INR 0.00
OraSure Technologies Inc $7.16 USD -0.29
Pernix Therapeutics Holdings Inc $10.73 USD -0.17
SciClone Pharmaceuticals Inc $7.71 USD 0.00
Sucampo Pharmaceuticals Inc $15.38 USD -0.62
View Industry Companies
 

Industry Analysis

MNTA

Industry Average

Valuation MNTA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 13.7x
Price/Book 3.5x
Price/Cash Flow NM Not Meaningful
TEV/Sales 10.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MOMENTA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.